Q: Was there an Excludes note change for subcategory G93.4- (other and unspecified encephalopathy) for fiscal year 2021? If so, how will it change any ICD-10-CM reporting and reimbursement for toxic encephalopathy and metabolic encephalopathy going forward?
Q: My organization is considering outsourcing our coding to an offshore company. Does HIPAA apply only to healthcare entities and business associates located within the United States? If so, what would happen if the offshore third party experiences a breach? What are the risks associated with this decision?
Q: With novel coronavirus (COVID-19) concerns still persisting, patients should be avoiding emergency department (ED) visits when possible. How can case managers help in this process?